Bioavailability of Extended-Release Nevirapine 400 and 300 mg in HIV-1: A Multicenter, Open-Label Study-Reference-Cited by-同舟云学术

Bioavailability of Extended-Release Nevirapine 400 and 300 mg in HIV-1: A Multicenter, Open-Label Study

Published:2011-09 Issue:9 Volume:33 Page:1308-1320
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Battegay Manuel,Arasteh Keikawus,Plettenberg Andreas,Bogner Johannes R.,Livrozet Jean-Michel,Witt Mallory D.,Mossdorf Erik,Yong Chan-Loi,Zhang Wei,Macha Sreeraj,Berger Frank,Stern Jerry,Robinson Patrick,Quinson Anne-Marie

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference11 articles.

1. The role of nevirapine in the treatment of HIV-1 disease;Podzamczer;Expert Opin Pharmacother,2001

2. Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness;Bangsberg;AIDS,2006

3. The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals;van Heeswijk;AIDS,2000

4. In vitro-in vivo correlation for nevirapine extended release tablets;Macha;Biopharm Drug Dispos,2009

5. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Presented at: 48th General Assembly; October 1996; Somerset West, Republic of South Africa.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential of Long-Acting, Tissue-Targeted Synthetic Nanotherapy for Delivery of Antiviral Therapy Against HIV Infection;Viruses;2020-04-07

2. Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy;European Journal of Pharmaceutics and Biopharmaceutics;2019-05

3. Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infection;HIV Clinical Trials;2017-11-02

4. Occurrence of HIV eradication for preexposure prophylaxis treatment with a deterministic HIV model;IET Systems Biology;2016-12

5. Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics;Current HIV Research;2015-11-02